8-K
filed May 14, 2026, 4:03 PM ET
ticker TLSI
CIK 0001826667
other material
confidence high
sentiment neutral
materiality 0.15
TriSalus annual meeting elects two directors, ratifies auditor, approves say-on-pay frequency
TriSalus Life Sciences, Inc.
- Mary Szela and Gary Gordon elected to three-year director terms with ~92% for votes.
- Grant Thornton LLP ratified as independent auditor for fiscal 2026.
- Advisory vote on exec compensation approved; board adopts three-year frequency for future votes.
- Turnout: 67.9% of outstanding shares represented at the meeting.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
TriSalus Life Sciences, Inc. shareholders approved Advisory vote on compensation of named executive officers at the 2026-05-14 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-05-14
Exact text from the filing
The proposal to approve, on an advisory basis, the compensation of the Company’s named executive officers was approved by the stockholder vote: For Against Abstain Broker Non-Votes 32,625,082 1,206,105 176,369 7,721,120
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
TriSalus Life Sciences, Inc. shareholders approved Ratification of appointment of Grant Thornton, LLP as independent registered accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-14 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-14
Exact text from the filing
The appointment of Grant Thornton, LLP to serve as our independent registered accounting firm for the fiscal year ending December 31, 2026 was ratified by the stockholder vote: For Against Abstain 41,098,385 28,667 601,624
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
TriSalus Life Sciences, Inc. shareholders approved Advisory vote on frequency of future stockholder advisory votes on named executive officer compensation at the 2026-05-14 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2026-05-14
Exact text from the filing
The proposal to approve, on an advisory basis, a three-year frequency with which the Company should conduct future stockholder advisory votes on named executive officer compensation was approved by the stockholder vote: 1 Year 2 Years 3 Years Abstain Broker Non-Votes 12,656,430 736,931 20,348,386 265,809 7,721,120
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
TriSalus Life Sciences, Inc. shareholders approved Election of Directors at the 2026-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-14
Exact text from the filing
The two nominees for Directors were elected to serve three-year terms to expire at the annual meeting of stockholders in 2029, as follows: Nominee For Withhold Broker Non-Votes Mary Szela 31,393,310 2,614,246 7,721,120 Gary Gordon 31,339,161 2,668,395 7,721,120
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.